Kristina Warton

384 Victoria Street
Darlinghurst, NSW 2010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Evaluating the utility of circulating cell-free DNA in the context of endometrial cancer: a systematic scoping review.

Evaluating the utility of circulating cell-free DNA in the context of endometrial cancer: a systematic scoping review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 11, 2026

Emerging biomarkers for the early detection of high-grade serous tubo-ovarian cancer.

Emerging biomarkers for the early detection of high-grade serous tubo-ovarian cancer.

Journal: Critical reviews in oncology/hematology

Published: October 14, 2025

Development and validation of a computational tool to predict treatment outcomes in cells from high-grade serous ovarian cancer patients.

Development and validation of a computational tool to predict treatment outcomes in cells from high-grade serous ovarian cancer patients.

Journal: Bioengineering & translational medicine

Published: October 21, 2024

Beyond 2D cell cultures: how 3D models are changing the in vitro study of ovarian cancer and how to make the most of them.

Beyond 2D cell cultures: how 3D models are changing the in vitro study of ovarian cancer and how to make the most of them.

Journal: PeerJ

Published: April 10, 2024

Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer.

Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer.

Journal: Molecular oncology

Published: March 26, 2024

Circulating cell-free DNA is elevated in postmenopausal compared with pre- and perimenopausal women.

Circulating cell-free DNA is elevated in postmenopausal compared with pre- and perimenopausal women.

Journal: Menopause (New York, N.Y.)

Published: February 22, 2024

Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach.

Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach.

Journal: Advanced biology

Published: January 19, 2024

Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.

Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.

Journal: Translational oncology

Published: July 10, 2023

Endogenous cell-free DNA in fetal bovine serum introduces artifacts to in vitro cell-free DNA models.

Endogenous cell-free DNA in fetal bovine serum introduces artifacts to in vitro cell-free DNA models.

Journal: BioTechniques

Published: November 07, 2022

Recovery Efficiency of Cell-Free DNA After Bisulfite Conversion.

Recovery Efficiency of Cell-Free DNA After Bisulfite Conversion.

Journal: Clinical chemistry

Published: July 19, 2022

Transcending Blood-Opportunities for Alternate Liquid Biopsies in Oncology.

Transcending Blood-Opportunities for Alternate Liquid Biopsies in Oncology.

Journal: Cancers

Published: February 08, 2022

Circulating cell-free endometrial DNA level is unaltered during menstruation and in endometriosis.

Circulating cell-free endometrial DNA level is unaltered during menstruation and in endometriosis.

Journal: Human reproduction (Oxford, England)

Published: January 13, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026